Loading stock…

CorVel Corporation (CRVL) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

CorVel Corporation

CRVLMarket cap $3.86BPrice $76.3

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

CorVel manages workers' comp and auto claims for insurers and employers, blending AI-driven analytics with nurse case management to cut costs. It processes millions of claims yearly without owning a single hospital bed.

In Bastion Portfolios?

52W Return+7%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+10%7

Revenue Forecast

Rev CAGR (1y)+4%4

Rev CAGR (3y)+2%2

Rev CAGR (5y)+2%2

Earnings Forecast

EPS Growth Y+1-3%3

EPS Growth Y+2+2%4

EPS Growth Y+3+2%4

Quality

Margins

EBIT Margin15%6

Net Income Margin12%6

Free Cash Flow Margin12%6

Debt

Net Debt/EBITDA-1.210

Efficiency

ROE31%9

ROA18%10

Earnings Stability88

GEAR+AVERAGE46

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)362

P/E Ratio (Forward 3y)351

P/BV9.42

EV Multiples

EV/EBITDA Fwd212

EV/EBIT Fwd273

Yield

Free Cash Flow Yield3.0%5

Dividend Yieldna–

Momentum

Short term

1 month return+15%10

3 month return+22%10

YTD return+13%7

Mid term

Price vs 52wHigh96%10

1 year return+4%5

Long term

3 year return+13%3

5 year return+34%5

Risk Shield

Price Risk

Beta0.57

Volatility44%4

Free Cash Flow

Free Cash Flow Margin12%6

Free Cash Flow Yield3.0%5

Quality

ROCE38%10

Earnings Stability88

Net Debt/EBITDA-1.210

02Growth

Is it actually growing, and how fast?

CRVLCorVel

Revenue FY26$959M

GROWTH RATING↗

WEAK17 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-3%3

EPS growth, FY28E+2%4

EPS growth, FY29E+2%4

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

Revenue grew 10%/yr over the last 3 years; forecasts see it cooling to 2%/yr.

Earnings are set to grow in step with sales (EPS about 2%/yr vs revenue 2%/yr). One year dips: EPS falls 3% next year.

WEAKNESSES

Growth is the weak spot here, trailing 83% of companies worldwide.

Revenue is set to grow 2%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG82 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+15%10

3-month return+22%10

YTD return+13%7

MID & LONG-TERM▾SCORE

% of 52-week high96%10

1-year return+4%5

3-year return+13%3

5-year return+34%5

MOMENTUM ASSESSMENT

STRENGTHS

It's up 4% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+15%), over three months (+22%) and so far this year (+13%).

WATCH

Average long-term results. Multi-year returns are middling (+13% over three years and +34% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on CorVel. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CRVLCorVel

Revenue FY26$959M

GROWTH RATING↗

WEAK17 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-3%3

EPS growth, FY28E+2%4

EPS growth, FY29E+2%4

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

Revenue grew 10%/yr over the last 3 years; forecasts see it cooling to 2%/yr.

Earnings are set to grow in step with sales (EPS about 2%/yr vs revenue 2%/yr). One year dips: EPS falls 3% next year.

WEAKNESSES

Growth is the weak spot here, trailing 83% of companies worldwide.

Revenue is set to grow 2%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that is slowing. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG82 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+15%10

3-month return+22%10

YTD return+13%7

MID & LONG-TERM▾SCORE

% of 52-week high96%10

1-year return+4%5

3-year return+13%3

5-year return+34%5

MOMENTUM ASSESSMENT

STRENGTHS

It's up 4% over the past year, now sitting right at its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+15%), over three months (+22%) and so far this year (+13%).

WATCH

Average long-term results. Multi-year returns are middling (+13% over three years and +34% over five), roughly average for the market.

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on CorVel. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community